Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mepolizumab Immune Profiles in CRSwNP
NCT05642806Phase 4Recruiting
- Sponsor
- St. Paul's Sinus Centre
- Start
- Jul 2023
- Primary completion
- Dec 2024
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of mepolizumab in chronic rhinosinusitis with nasal polyps (CRSwNP), sponsored by St. Paul's Sinus Centre. Started Jul 2023; status: recruiting.
02
Drugs
mepolizumab
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on NCT05642806.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05642806.